Sigachi Industries Limited
Sigachi Industries Limited (SIGACHI) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals
sigachi.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-02
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 99 Cr | 111 Cr | 104 Cr | 96 Cr | 125 Cr | 139 Cr | 128 Cr | 128 Cr | 110 Cr | 117 Cr | 122 Cr | 121 Cr |
| Operating expenses (approx.) | 78 Cr | 88 Cr | 88 Cr | 75 Cr | 108 Cr | 106 Cr | 100 Cr | 104 Cr | 103 Cr | 111 Cr | 105 Cr | 105 Cr |
| EBITDA | 21 Cr | 23 Cr | 16 Cr | 21 Cr | 17 Cr | 33 Cr | 29 Cr | 24 Cr | 8 Cr | 6 Cr | 16 Cr | 17 Cr |
| OPM % | 21.6% | 20.4% | 15.7% | 22.0% | 13.8% | 23.8% | 22.3% | 18.8% | 6.8% | 4.9% | 13.5% | 13.6% |
| Other income | 1 Cr | 2 Cr | 7 Cr | 2 Cr | 15 Cr | 2 Cr | 2 Cr | 4 Cr | 2 Cr | 0.47 Cr | 1 Cr | 1 Cr |
| Interest | 2 Cr | 2 Cr | 3 Cr | 3 Cr | 2 Cr | 4 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 4 Cr | 3 Cr |
| Depreciation | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 3 Cr | 5 Cr | 5 Cr | 5 Cr | 4 Cr | 4 Cr | 5 Cr | 4 Cr |
| Profit before tax | 18 Cr | 20 Cr | 17 Cr | 16 Cr | 27 Cr | 27 Cr | 23 Cr | -101 Cr | 7 Cr | -2 Cr | 8 Cr | 10 Cr |
| Tax % | 17.0% | 18.0% | 11.9% | 22.2% | 20.8% | 23.2% | 28.7% | 0.0% | -41.6% | 99.1% | 0.8% | 19.3% |
| Net profit | 15 Cr | 16 Cr | 15 Cr | 13 Cr | 21 Cr | 21 Cr | 16 Cr | -101 Cr | 11 Cr | -0.02 Cr | 8 Cr | 8 Cr |
| EPS (₹) | ₹4.93 | ₹0.51 | ₹0.48 | ₹0.40 | ₹0.66 | ₹0.65 | ₹0.36 | ₹-2.63 | ₹0.28 | ₹0.01 | ₹0.20 | ₹0.18 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 250 Cr | 302 Cr | 399 Cr | 488 Cr | 478 Cr | Sign in for TTM |
| Operating expenses (approx.) | 197 Cr | 243 Cr | 322 Cr | 388 Cr | 424 Cr | Sign in for TTM |
| EBITDA | 53 Cr | 59 Cr | 77 Cr | 100 Cr | 54 Cr | Sign in for TTM |
| OPM % | 21.2% | 19.4% | 19.2% | 20.5% | 11.2% | Sign in for TTM |
| Other income | 3 Cr | 7 Cr | 12 Cr | 21 Cr | 8 Cr | Sign in for TTM |
| Interest | 1 Cr | 4 Cr | 8 Cr | 12 Cr | 14 Cr | Sign in for TTM |
| Depreciation | 3 Cr | 7 Cr | 11 Cr | 16 Cr | 18 Cr | Sign in for TTM |
| Profit before tax | 52 Cr | 54 Cr | 70 Cr | 92 Cr | -88 Cr | Sign in for TTM |
| Tax % | 22.4% | 20.1% | 17.9% | 23.7% | 5.6% | Sign in for TTM |
| Net profit | 40 Cr | 44 Cr | 57 Cr | 70 Cr | -83 Cr | Sign in for TTM |
| EPS (₹) | ₹15.44 | ₹14.16 | ₹1.81 | ₹2.06 | ₹-2.14 | Sign in for TTM |
| Dividend payout % | 5.8% | 7.1% | 5.4% | 4.7% | — | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 31 Cr | 31 Cr | 33 Cr | 38 Cr | 38 Cr |
| Reserves | 197 Cr | 238 Cr | 397 Cr | 563 Cr | 491 Cr |
| Borrowings | 34 Cr | 40 Cr | 143 Cr | 142 Cr | 136 Cr |
| Other liabilities | 25 Cr | 65 Cr | 110 Cr | 91 Cr | 177 Cr |
| Total liabilities | 287 Cr | 374 Cr | 694 Cr | 846 Cr | 841 Cr |
| Fixed assets (net) | 53 Cr | 122 Cr | 171 Cr | 288 Cr | 240 Cr |
| CWIP | 10 Cr | 35 Cr | 97 Cr | 9 Cr | 31 Cr |
| Investments | 0.15 Cr | 0.15 Cr | 0.29 Cr | 0.15 Cr | 0.15 Cr |
| Inventories | 30 Cr | 47 Cr | 71 Cr | 94 Cr | 74 Cr |
| Trade receivables | 60 Cr | 80 Cr | 150 Cr | 184 Cr | 224 Cr |
| Cash & bank | 29 Cr | 14 Cr | 17 Cr | 17 Cr | 21 Cr |
| Other assets | 105 Cr | 77 Cr | 188 Cr | 255 Cr | 252 Cr |
| Total assets | 287 Cr | 374 Cr | 694 Cr | 846 Cr | 841 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operating activity | 6 Cr | 29 Cr | 13 Cr | 27 Cr | 4 Cr |
| Cash from investing | -63 Cr | -92 Cr | -161 Cr | -93 Cr | -53 Cr |
| Cash from financing | 108 Cr | 26 Cr | 172 Cr | 81 Cr | 2 Cr |
| Net cash flow | 51 Cr | -37 Cr | 24 Cr | 15 Cr | -46 Cr |
| Free cash flow (OCF − Capex) | -18 Cr | -72 Cr | -72 Cr | -16 Cr | -37 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2022BSE balance sheet (this exchange's own filing had none for this period) | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROCE % | 23.2% | 19.0% | 13.3% | 13.9% | -11.1% |
| ROE % | 17.6% | 16.2% | 13.0% | 11.3% | -15.5% |
| Debtor days | 87 | 97 | 137 | 137 | 171 |
| Inventory days | 90 | 120 | 161 | 146 | 134 |
| Days payable | 31 | 54 | 109 | 55 | 107 |
| Cash conversion cycle | 146 | 163 | 189 | 228 | 198 |
| Debt / equity | 0.00 | 0.15 | 0.33 | 0.24 | 0.26 |
| Current ratio | 3.50 | 2.38 | 1.67 | 2.13 | 1.44 |
| Net debt / EBITDA | 0.00 | 0.46 | 1.64 | 1.25 | 2.13 |
Compare with peers
Loading peers…